Retained Earnings
Pfizer Retained Earnings increased by 2.3% to $117.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.0%, from $119.59B to $117.24B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 4.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increasing balance indicates consistent profitability and successful capital reinvestment, while a decrease may signal net losses or aggressive dividend payouts.
Detailed definition
This represents the cumulative net income of the company that has been reinvested into the business rather than distribu...
Peer comparison
Large-cap pharmaceutical peers typically maintain high retained earnings due to long-term capital reinvestment in drug development.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.35B | $102.25B | $103.39B | $111.19B | $116.61B | $122.97B | $125.66B | $131.10B | $128.80B | $126.41B | $118.35B | $121.32B | $116.60B | $121.06B | $116.73B | $119.59B | $117.61B | $121.15B | $114.61B | $117.24B |
| QoQ Change | — | +6.1% | +1.1% | +7.5% | +4.9% | +5.5% | +2.2% | +4.3% | -1.8% | -1.9% | -6.4% | +2.5% | -3.9% | +3.8% | -3.6% | +2.5% | -1.7% | +3.0% | -5.4% | +2.3% |
| YoY Change | — | — | — | — | +21.0% | +20.3% | +21.5% | +17.9% | +10.5% | +2.8% | -5.8% | -7.5% | -9.5% | -4.2% | -1.4% | -1.4% | +0.9% | +0.1% | -1.8% | -2.0% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Pfizer's retained earnings?
- Pfizer (PFE) reported retained earnings of $117.24B in Q1 2026.
- How has Pfizer's retained earnings changed year-over-year?
- Pfizer's retained earnings decreased by 2.0% year-over-year, from $119.59B to $117.24B.
- What is the long-term trend for Pfizer's retained earnings?
- Over 5 years (2020 to 2025), Pfizer's retained earnings has grown at a 4.9% compound annual growth rate (CAGR), from $90.39B to $114.61B.
- What does retained earnings mean?
- The total historical profits a company has kept and reinvested in itself instead of paying out to shareholders.